B CELL LYMPHOMA
Clinical trials for B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR t therapy targets tough lymphoma in early trial
Disease control OngoingThis early-phase study tests a new type of CAR T cell therapy for adults with large B-cell lymphoma that has come back or not responded to treatment. The therapy uses specially modified immune cells to find and attack cancer cells. The main goals are to check safety and find the …
Matched conditions: B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in people with advanced blood cancers (like leukemia, lymphoma, or multiple myeloma) who have already tried standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors or impro…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Blood cancer drug Pirtobrutinib's Long-Term safety under review
Disease control OngoingThis study looks at the long-term safety of the drug pirtobrutinib in people with certain blood cancers, like chronic lymphocytic leukemia or non-Hodgkin lymphoma. It includes 13 participants who already completed an earlier study and are still benefiting from the treatment. They…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches over people who have already received Caribou cell therapy in earlier studies. The goal is to track any long-term side effects and safety issues for up to 15 years after treatment. About 150 participants with certain blood cancers will be followed without recei…
Matched conditions: B CELL LYMPHOMA
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:13 UTC